Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Diagnostic Medical Systems ( (FR:ALDMS) ) has shared an update.
Diagnostic Medical Systems (DMS) Group announced a video conference for shareholders and investors scheduled for January 16, 2025, coinciding with the release of their 2024 annual revenue. The event will feature presentations from key executives and provide a platform for participants to engage directly with management. This initiative aims to foster transparency and strengthen relationships with stakeholders, highlighting DMS Group’s commitment to communication and engagement in the competitive medical imaging industry.
More about Diagnostic Medical Systems
DMS Group is a French manufacturer specializing in high-performance medical imaging systems, particularly in Digital Radiology and Osteodensitometry. The company is recognized internationally, with 75% of its €42.2 million revenue in 2023 coming from international markets. It operates through a network of over 140 national distributors across all continents and is listed on the Euronext Growth Paris market.
YTD Price Performance: 5.79%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €13.54M
Find detailed analytics on ALDMS stock on TipRanks’ Stock Analysis page.